NASDAQ · SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC · LARGE CAP
Acadia Healthcare Company, Inc. ACHC
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.3B
▲ 5.0% vs FY2024
EPS · FY25
$-12.16
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-43.9%
Net margin · FY25
-33.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.3B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 33 cents on every revenue dollar this year.
Per share
USD -12.16
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-43.9%
Return on equity, FY2025
ROE
Operating margin-32.2%
Net margin-33.3%
Return on assets-19.2%
Each USD of equity lost 44 cents this year.
Returned to shareholders
USD 50.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 50.0M
Share of profit-4.5%
Consecutive raises—
USD 50.0M in buybacks went back to shareholders in a year without profit.
Growth
+9.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+8.3%
+9.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.09B
Shares outstanding, FY2025
Change, 5 years+2.8%
Change, 10 years+27.9%
The share count grew 3% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.5B
total assets, end of FY2025
Total assetsUSD 5.5B
EquityUSD 1.9B
CashUSD 133.2M
Gross debtUSD 2.5B
Net debtUSD 2.4B
Current ratio1.55×
Net debt stands at 121% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
3.3
3.2
2.9
2.6
2.3
2.1
2.0
1.9
2.8
2.8
·
·
·
·
·
·
·
Operating income $B
−1.1
0.3
−0.0
0.4
0.3
0.2
0.1
0.1
0.6
0.6
0.4
0.2
0.1
0.1
−0.0
0.0
0.0
EBITDA $B
−0.9
0.5
0.1
0.5
0.4
0.3
0.2
0.1
0.7
0.7
0.5
0.2
0.2
0.1
−0.0
0.0
0.0
Income tax $B
0.0
0.1
−0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.1
0.0
0.0
0.0
−0.0
0.0
0.0
Net income $B
−1.1
0.3
−0.0
0.3
0.2
−0.7
0.1
−0.2
0.2
0.0
0.1
0.1
0.0
0.0
−0.0
0.0
0.0
EPS, diluted $
−12.16
2.78
−0.24
2.98
2.10
−7.59
1.24
−2.01
2.30
0.07
1.64
1.50
0.85
0.53
−1.86
0.35
0.16
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−43.9
8.7
−0.8
10.2
8.6
−30.5
4.5
−7.2
8.4
0.3
8.8
12.2
9.3
7.7
−57.4
24.7
·
Shares out B
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.09
0.07
0.06
0.05
0.05
0.03
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed